Harvard University   Report issue

Contributed to NME Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cambridge MA United States (1636)

Organization Overview

First Clinical Trial
1977
NCT00000493
First Marketed Drug
1944
immune globulin (human)
First NDA Approval
1944
immune globulin (human)
Last Known Activity
2022

Timeline

NOW
  • Now